{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["4(3)"],"submitter":["Sanchez-Martinez D"],"pubmed_abstract":["Natural killer (NK) cells recognize and eliminate transformed or infected cells that have downregulated MHC class-I and express specific activating ligands. Recent evidence indicates that allogeneic NK cells are useful to eliminate haematological cancer cells independently of MHC-I expression. However, it is unclear if transformed cells expressing mutations that confer anti-apoptotic properties and chemoresistance will be susceptible to NK cells. Allogeneic primary human NK cells were activated using different protocols and prospectively tested for their ability to eliminate diverse mutant haematological and apoptotic-resistant cancer cell lines as well as patient-derived B-cell chronic lymphocytic leukemia cells with chemotherapy multiresistance. Here, we show that human NK cells from hea"],"journal":["Oncoimmunology"],"pagination":["e991613"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC4404803"],"repository":["biostudies-literature"],"pubmed_title":["Human NK cells activated by EBV<sup>+</sup> lymphoblastoid cells overcome anti-apoptotic mechanisms of drug resistance in haematological cancer cells."],"pmcid":["PMC4404803"],"pubmed_authors":["Muntasell A","Naval J","Aguilo N","Sanchez-Martinez D","Villalba M","Nunez D","Pardo J","Marzo I","Anel A","Vilches C","Azaceta G","Galvez EM","Palomera L"],"additional_accession":[]},"is_claimable":false,"name":"Human NK cells activated by EBV<sup>+</sup> lymphoblastoid cells overcome anti-apoptotic mechanisms of drug resistance in haematological cancer cells.","description":"Natural killer (NK) cells recognize and eliminate transformed or infected cells that have downregulated MHC class-I and express specific activating ligands. Recent evidence indicates that allogeneic NK cells are useful to eliminate haematological cancer cells independently of MHC-I expression. However, it is unclear if transformed cells expressing mutations that confer anti-apoptotic properties and chemoresistance will be susceptible to NK cells. Allogeneic primary human NK cells were activated using different protocols and prospectively tested for their ability to eliminate diverse mutant haematological and apoptotic-resistant cancer cell lines as well as patient-derived B-cell chronic lymphocytic leukemia cells with chemotherapy multiresistance. Here, we show that human NK cells from hea","dates":{"release":"2015-01-01T00:00:00Z","publication":"2015 Mar","modification":"2026-07-10T03:21:06.251Z","creation":"2019-03-27T01:50:15Z"},"accession":"S-EPMC4404803","cross_references":{"pubmed":["25949911"],"doi":["10.4161/2162402x.2014.991613","10.4161/2162402X.2014.991613"]}}